Importer of Controlled Substances Application: Perkinelmer, Inc., 15711-15712 [2021-06029]
Download as PDF
<![CDATA[
15711
Federal Register / Vol. 86, No. 55 / Wednesday, March 24, 2021 / Notices
transition brewing agreement. Between
the two facilities MBC and KBC, we
would have capacity, redundancy and
true economies of scale to execute this
plan completely free from ABI
influence.
I have prepared a spreadsheet with
data from my analysis of the publicly
available information from the new
brewery construction along with
valuation metrics for the company. I can
share this at the appropriate time in our
discussion.
In closing we feel that the divestiture
process was unfairly administered, and
a buyer was selected for their clear ties
to ABI and the desire to maintain
influence. We are still an interested
party and would like the opportunity to
be considered as a buyer for the Kona
Brewing assets within Hawai1i.
Sincerely,
/s/
Garrett W. Marrero
CEO, Founder,
Maui Brewing Co.
[FR Doc. 2021–05988 Filed 3–23–21; 8:45 am]
BILLING CODE 4410–11–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–813]
Importer of Controlled Substances
Application: Shertech Laboratories,
LLC
Drug
code
Controlled substance
I
Cocaine ........................
9041
Schedule
III
The company plans to import
synthetic derivatives of the listed
controlled substance in bulk form to
conduct clinical trials. No other activity
for this drug code is authorized for this
registration.
Approval of permit applications will
occur only when the registrant’s
business activity is consistent with what
is authorized under 21 U.S.C. 952(a)(2).
Authorization will not extend to the
import of Food and Drug
Administration-approved or nonapproved finished dosage forms for
commercial sale.
William T. McDermott,
Assistant Administrator.
Drug Enforcement
Administration, Justice.
ACTION: Notice of application.
[FR Doc. 2021–06031 Filed 3–23–21; 8:45 am]
Shertech Laboratories, LLC
has applied to be registered as an
importer of basic class(es) of controlled
substance(s). Refer to Supplemental
Information listed below for further
drug information.
DATES: Registered bulk manufacturers of
the affected basic class(es), and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before April 23, 2021. Such persons
may also file a written request for a
hearing on the application on or before
April 23, 2021.
ADDRESSES: Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152. All requests for a hearing must
be sent to: Drug Enforcement
Administration, Attn: Administrator,
8701 Morrissette Drive, Springfield,
Virginia 22152. All requests for a
hearing should also be sent to: (1) Drug
DEPARTMENT OF JUSTICE
AGENCY:
SUMMARY:
khammond on DSKJM1Z7X2PROD with NOTICES
Enforcement Administration, Attn:
Hearing Clerk/OALJ, 8701 Morrissette
Drive, Springfield, Virginia 22152; and
(2) Drug Enforcement Administration,
Attn: DEA Federal Register
Representative/DPW, 8701 Morrissette
Drive, Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: In
accordance with 21 CFR 1301.34(a), this
is notice that on March 1, 2021,
Shertech Laboratories, LLC, 1185 Woods
Chapel Road, Duncan, South Carolina
29334, applied to be registered as an
importer of the following basic class(es)
of controlled substance(s):
VerDate Sep<11>2014
16:30 Mar 23, 2021
Jkt 253001
BILLING CODE 4410–09–P
Drug Enforcement Administration
[Docket No. DEA–812]
Importer of Controlled Substances
Application: Medi-Physics Inc dba GE
Healthcare
hearing on the application on or before
April 23, 2021.
ADDRESSES: Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152. All requests for a hearing must
be sent to: Drug Enforcement
Administration, Attn: Administrator,
8701 Morrissette Drive, Springfield,
Virginia 22152. All requests for a
hearing should also be sent to: (1) Drug
Enforcement Administration, Attn:
Hearing Clerk/OALJ, 8701 Morrissette
Drive, Springfield, Virginia 22152; and
(2) Drug Enforcement Administration,
Attn: DEA Federal Register
Representative/DPW, 8701 Morrissette
Drive, Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: In
accordance with 21 CFR 1301.34(a), this
is notice that on February 26, 2021,
Medi-Physics Inc dba GE Healthcare,
3350 North Ridge Avenue, Arlington
Heights, Illinois 60004–1412, applied to
be registered as an importer of the
following basic class(es) of controlled
substance(s):
Controlled substance
Ecgonine .......................
Drug
code
9180
Schedule
II
The company plans to import
derivatives of the controlled substance
to be used for the manufacture a
diagnostic product and reference
standards. No other activity for this drug
code is authorized for this registration.
Approval of permit applications will
occur only when the registrant’s
business activity is consistent with what
is authorized under 21 U.S.C. 952(a)(2).
Authorization will not extend to the
import of Food and Drug
Administration-approved or nonapproved finished dosage forms for
commercial sale.
William T. McDermott,
Assistant Administrator.
Drug Enforcement
Administration, Justice.
ACTION: Notice of application.
AGENCY:
[FR Doc. 2021–06030 Filed 3–23–21; 8:45 am]
BILLING CODE 4410–09–P
Medi-Physics Inc dba GE
Healthcare has applied to be registered
as an importer of basic class(es) of
controlled substance(s). Refer to
Supplemental Information listed below
for further drug information.
DATES: Registered bulk manufacturers of
the affected basic class(es), and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before April 23, 2021. Such persons
may also file a written request for a
SUMMARY:
PO 00000
Frm 00072
Fmt 4703
Sfmt 4703
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–811]
Importer of Controlled Substances
Application: Perkinelmer, Inc.
Drug Enforcement
Administration, Justice.
ACTION: Notice of application.
AGENCY:
E:\FR\FM\24MRN1.SGM
24MRN1
15712
Federal Register / Vol. 86, No. 55 / Wednesday, March 24, 2021 / Notices
Perkinelmer, Inc. has applied
to be registered as an importer of basic
class(es) of controlled substance(s).
Refer to Supplemental Information
listed below for further drug
information.
SUMMARY:
Registered bulk manufacturers of
the affected basic class(es), and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before April 23, 2021. Such persons
may also file a written request for a
hearing on the application on or before
April 23, 2021.
DATES:
Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152. All requests for a hearing must
be sent to: Drug Enforcement
Administration, Attn: Administrator,
8701 Morrissette Drive, Springfield,
Virginia 22152. All request for a hearing
should also be sent to: (1) Drug
Enforcement Administration, Attn:
Hearing Clerk/OALJ, 8701 Morrissette
Drive, Springfield, Virginia 22152; and
(2) Drug Enforcement Administration,
Attn: DEA Federal Register
Representative/DPW, 8701 Morrissette
Drive, Springfield, Virginia 22152.
ADDRESSES:
In
accordance with 21 CFR 1301.34(a), this
is notice that on February 23, 2021,
Perkinelmer, Inc., 120 East Dedham
Street, Boston, Massachusetts 02118–
2852, applied to be registered as an
importer of the following basic class(es)
of controlled substance(s):
SUPPLEMENTARY INFORMATION:
Drug
code
Controlled substance
khammond on DSKJM1Z7X2PROD with NOTICES
Lysergic Acid
Diethylamide.
Thebaine .......................
I
Schedule
7315
I
9333
I II
The company plans to import the
listed controlled substances for bulk
manufacturing of the radioactive form
and sold to its customers for research
purposes. Drug code 9333 (Thebaine)
will be used to import the Thebaine
derivative Diprenorphine. No other
activity for this drug code is authorized
for this registration.
Approval of permit applications will
occur only when the registrant’s
business activity is consistent with what
is authorized under 21 U.S.C. 952(a)(2).
Authorization will not extend to the
import of Food and Drug
Administration-approved or non-
VerDate Sep<11>2014
16:30 Mar 23, 2021
Jkt 253001
approved finished dosage forms for
commercial sale.
https://www.justice.gov/enrd/consentdecrees.
William T. McDermott,
Assistant Administrator.
Cherie Rogers,
Assistant Section Chief, Environmental
Defense Section, Environment and Natural
Resources Division.
[FR Doc. 2021–06029 Filed 3–23–21; 8:45 am]
BILLING CODE 4410–09–P
[FR Doc. 2021–06044 Filed 3–23–21; 8:45 am]
BILLING CODE 4410–CW–P
DEPARTMENT OF JUSTICE
Notice of Lodging Proposed Consent
Decree
In accordance with Departmental
Policy, 28 CFR 50.7, notice is hereby
given that a proposed Consent Decree in
United States v. John Raftopoulos, et al.,
Civil Action No. 1:20–CV–03166–SKC,
was lodged with the United States
District Court for the District of
Colorado on March 18, 2021.
This proposed Consent Decree
concerns a complaint filed by the
United States against Defendants John
Raftopoulos, Diamond Peak Cattle
Company, LLC, and Rancho Greco
Limited, LLC, pursuant to Section 309
of the Clean Water Act, 33 U.S.C. 1319,
to obtain injunctive relief from and
impose civil penalties against the
Defendants for violating the Clean Water
Act by discharging pollutants without a
permit into waters of the United States.
The complaint also seeks to obtain
injunctive relief and damages from the
Defendants for violating Sections 302,
303, and 310 of the Federal Land Policy
and Management Act of 1976, 43 U.S.C.
1732, 1733 and 1740, and for trespass
on federal public lands. The proposed
Consent Decree resolves these
allegations by requiring the Defendants
to restore the impacted areas and to pay
civil penalties and damages.
The Department of Justice will accept
written comments relating to this
proposed Consent Decree for thirty (30)
days from the date of publication of this
Notice. Please address comments to
Alan Greenberg, United States
Department of Justice, Environment and
Natural Resources Division,
Environmental Defense Section, 999
18th Street, Suite 370, Denver, CO
80202, pubcomment_eds.enrd@
usdoj.gov, and refer to United States v.
Raftopoulos, et al., DJ #90–5–1–1–
21104.
The proposed Consent Decree may be
examined at the Clerk’s Office, United
States District Court for the District of
Colorado, Alfred A. Arraj Courthouse,
901 19th Street, Denver, CO 80294. In
addition, the proposed Consent Decree
may be examined electronically at
PO 00000
Frm 00073
Fmt 4703
Sfmt 4703
DEPARTMENT OF JUSTICE
National Institute of Justice
[OJP (NIJ) Docket No. 1790]
Law Enforcement Mental Health and
Wellness Application Software Market
Survey
National Institute of Justice
(NIJ), Office of Justice Programs, Justice.
ACTION: Notice of request for
information.
AGENCY:
The National Institute of
Justice (NIJ) is soliciting information for
use in an upcoming Criminal Justice
Testing and Evaluation Consortium
(CJTEC) report that will provide a
landscape view of application software
for mental health and wellness in the
law enforcement community. The report
will highlight the vendors/developers
creating mental health and wellness
application software products (apps)
directed to law enforcement end users
and other first responders. The report
will also consider these mental health
and wellness apps in terms of the
broader context of the rapidly evolving
marketplace for fitness and health and
wellness products for consumer and
medical applications.
DATES: Emailed responses must be
received (and mailed responses
postmarked) by 5:00 p.m. Eastern Time
on May 10, 2021.
ADDRESSES: Responses to this request
may be submitted electronically by
email to Blaide Woodburn at
bwoodburn.contractor@rti.org with the
subject line ‘‘Law Enforcement Mental
Health and Wellness Application
Software Market Survey Federal
Register Response.’’ Responses may also
be sent by mail to the following address:
Criminal Justice Testing and Evaluation
Consortium (CJTEC), ATTN: Blaide
Woodburn, Law Enforcement Mental
Health and Wellness Application
Software Market Survey Federal
Register Response, RTI International,
P.O. Box 12194, 3040 E Cornwallis
Road, Research Triangle Park, NC
27709–2194.
FOR FURTHER INFORMATION CONTACT: For
more information on this market survey,
please contact Matt Mecray (CJTEC) by
SUMMARY:
E:\FR\FM\24MRN1.SGM
24MRN1
]]>Agencies
[Federal Register Volume 86, Number 55 (Wednesday, March 24, 2021)]
[Notices]
[Pages 15711-15712]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-06029]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-811]
Importer of Controlled Substances Application: Perkinelmer, Inc.
AGENCY: Drug Enforcement Administration, Justice.
ACTION: Notice of application.
-----------------------------------------------------------------------
[[Page 15712]]
SUMMARY: Perkinelmer, Inc. has applied to be registered as an importer
of basic class(es) of controlled substance(s). Refer to Supplemental
Information listed below for further drug information.
DATES: Registered bulk manufacturers of the affected basic class(es),
and applicants therefore, may file written comments on or objections to
the issuance of the proposed registration on or before April 23, 2021.
Such persons may also file a written request for a hearing on the
application on or before April 23, 2021.
ADDRESSES: Written comments should be sent to: Drug Enforcement
Administration, Attention: DEA Federal Register Representative/DPW,
8701 Morrissette Drive, Springfield, Virginia 22152. All requests for a
hearing must be sent to: Drug Enforcement Administration, Attn:
Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. All
request for a hearing should also be sent to: (1) Drug Enforcement
Administration, Attn: Hearing Clerk/OALJ, 8701 Morrissette Drive,
Springfield, Virginia 22152; and (2) Drug Enforcement Administration,
Attn: DEA Federal Register Representative/DPW, 8701 Morrissette Drive,
Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.34(a), this
is notice that on February 23, 2021, Perkinelmer, Inc., 120 East Dedham
Street, Boston, Massachusetts 02118-2852, applied to be registered as
an importer of the following basic class(es) of controlled
substance(s):
------------------------------------------------------------------------
Drug
Controlled substance code Schedule
------------------------------------------------------------------------
Lysergic Acid Diethylamide............. 7315 I
Thebaine............................... 9333 II
------------------------------------------------------------------------
The company plans to import the listed controlled substances for
bulk manufacturing of the radioactive form and sold to its customers
for research purposes. Drug code 9333 (Thebaine) will be used to import
the Thebaine derivative Diprenorphine. No other activity for this drug
code is authorized for this registration.
Approval of permit applications will occur only when the
registrant's business activity is consistent with what is authorized
under 21 U.S.C. 952(a)(2). Authorization will not extend to the import
of Food and Drug Administration-approved or non-approved finished
dosage forms for commercial sale.
William T. McDermott,
Assistant Administrator.
[FR Doc. 2021-06029 Filed 3-23-21; 8:45 am]
BILLING CODE 4410-09-P
